Clinical Trial News and Research

RSS
Review findings released on the safety of antidepressants (SSRI's)

Review findings released on the safety of antidepressants (SSRI's)

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Heart Hospital begins experimental cell therapy

Heart Hospital begins experimental cell therapy

New drug can successfully treat patients who have become resistant to Gleevec

New drug can successfully treat patients who have become resistant to Gleevec

Researchers step closer to cure for common childhood cancer

Researchers step closer to cure for common childhood cancer

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Single dose phase I data on CG53135 for the prevention of oral mucositis

Single dose phase I data on CG53135 for the prevention of oral mucositis

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Novel anti-obesity compound shows promise for treatment of obesity

Novel anti-obesity compound shows promise for treatment of obesity

Potential vaccine for the deadly toxin ricin

Potential vaccine for the deadly toxin ricin

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

New trial to test cancer smart drugs

New trial to test cancer smart drugs

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

FDA approval of Tysabri, for the treatment of multiple sclerosis

FDA approval of Tysabri, for the treatment of multiple sclerosis

FDA approves Tarceva (erlotinib)

FDA approves Tarceva (erlotinib)

Premature infants with lung disease may continue to require replacement substance to ease breathing

Premature infants with lung disease may continue to require replacement substance to ease breathing

Transcranial Magnetic Stimulation to treat major depression

Transcranial Magnetic Stimulation to treat major depression

Prolonged abstinence, no visual problems in patients taking GVG for meth/cocaine abuse

Prolonged abstinence, no visual problems in patients taking GVG for meth/cocaine abuse

Biotoxin from puffer fish may provide treatment for opioid withdrawal

Biotoxin from puffer fish may provide treatment for opioid withdrawal